[1]
“A Meta-Analysis of PCSK9 Inhibitors Versus Statins for LDL Cholesterol Reduction and Cardiovascular Outcomes”, ccm, vol. 9, no. 6, pp. 491–498, Dec. 2025, Accessed: Sep. 17, 2026. Available: https://fortunejournals.org/ojs/index.php/ccm/article/view/16664